scholarly journals CORRELATION OF HIGHER MATERNAL BLOOD SUGAR LEVELS WITH NEONATAL BIRTH WEIGHT IN NON-DIABETIC PREGNANT MOTHERS.

2016 ◽  
Vol 4 (4) ◽  
pp. 759-761
Author(s):  
Mahek Mukhi ◽  
◽  
Vandana. R Nimbargi ◽  
Savita. S Mehendale ◽  
◽  
...  
2021 ◽  
Vol 7 (1) ◽  
pp. 51-58
Author(s):  
Ely Nur Fauziyah ◽  
Sri Dinengsih ◽  
Risza Choirunissa

ABSTRACT UTERI FUNDUS HIGH RELATIONSHIP, BLOOD SUGAR AND CONDITIONSHEMOGLOBIN MOM WITH A NEW BORN WEIGHT  Background : Maternal and infant mortality rates are indicators commonly used to determine the degree of public health, assessment of the success of other health development programs. Low birth weight accounted for 51% of neonatal deaths throughout birth. The size of the birth weight depends on how the intrauterine fetus develops during pregnancy. This birth weight is one of the indicators of newborn health.Purpose: This research to find out the relationship between Uterine Fundus Height, Blood Sugar Levels, Hemoglobin Levels of mothers with weight and newborns at Puskesmas Sindang Jaya Year 2020.Method : This research is an Analytical Survey research with Cross Sectional design. The sample in this study of pregnant women who gave birth from june to August as many as 40 people.Results : In the results that there is a statistically significant relationship between high fundus uteri, blood sugar levels, and hemoglobin levels of mothers with baby weight born in the puskesmas sindang jaya with p value of 0.013 for high fudus ureteri, p value 0.042 for blood sugar levels, and p value of 0.069 for hemoglobin levels. Which means that all three variables have a p value of <0.05). With the variable that most affects the baby's weight is a high variable fundus erteri with a value (OR : 24).Conclusion : There is a link between high uterine fundus, blood sugar levels, and hemoglobin levels of mothers with newborn weight at Puskesmas Sindang Jaya Year 2020Suggestion  It is hoped that the next researcher can conduct further research because there are still many factors that can affect the weight of the newborn. Keywords : Baby Weight Born, Uterine Fundus Height, Blood Sugar Levels, Hemoglobin Levels. ABSTRAK Latar Belakang : Angka kematian ibu dan bayi adalah indikator yang lazim digunakan untuk menentukan derajat kesehatan masyarakat, penilaian terhadap keberhasilan pelayanan kesehatan program pembangunan kesehatan lainnya. Beratbayilahirrendahmenyumbang sebesar51%sebagaipenyebabkematianneonataldiseluruh kelahiran.Besar kecilnyaberatbadanlahirtergantungbagaimana pertumbuhan janinintrauterine selama kehamilan.Beratbadanlahirinilahyang menjadi salahsatuindikator kesehatanbayi baru lahir.Tujuan : Penelitian ini untuk mengetahui hubungan antara tinggi fundus uteri, kadar gula darah, dan kadar hemoglobin ibu dengan berat dan bayi baru lahir di Puskesmas Sindang Jaya Tahun 2020.Metode : Penelitian ini adalah penelitianSurvei AnalitikdenganrancanganCross Sectional. Sampel dalam penelitian ini ibu hamil yang melahirkan dari bulan juni-agustus sebanyak 40 orang.Hasil: Di dapatkan hasil bahwaterdapathubungan secarastatistiksignifikanantaratinggi fundus uteri, kadar gula darah, dan kadar hemoglobin ibu  dengan berat badan bayi lahir di puskesmas sindang jaya dengan p value 0.013 untuk tinggi fudus uteri, p value 0.042 untuk kadar gula darah, dan p value 0.069 untuk kadar hemoglobin. Yang artinya dari ketiga variabel memiliki nilai p value <0,05. Dengan variabel yang paling mempengaruhi berat badan bayi adalah variabel tinggi fundus uteri dengan nilai (OR : 24).Kesimpulan : Ada hubungan antara tinggi fundus uterus, kadar gula darah, dan kadar hemoglobin ibu dengan berat badan bayi baru lahir di Puskesmas Sindang Jaya Tahun 2020Saran: Diharapkan bagi peneliti selanjutnya dapat melakukan penelitian lebih lanjut dikarenakan masih banyak faktor yang dapat mempengaruhi berat badan bayi baru lahir.Kata Kunci : Berat Bayi Lahir, Tinggi Fundus Uteri, Kadar Gula Darah, Kadar Hemoglobin. 


1955 ◽  
Vol 18 (4) ◽  
pp. 553-554 ◽  
Author(s):  
Jørgen Pedersen

SUMMARY Birth weight and length of 122 surviving babies of diabetics, born in Rigshospitalet, Copenhagen 1926–1947, was compared to a control group of 122 infants of non-diabetics (matched controls). The groups were comparable, especially as to foetal age and parity of the mother, severe complications in the mothers, etc. The average foetal age was 261 days (range 237–301). The average weight and length for the infants of non-diab. controls was 3045 gm. and 49.5 cm., for infants of diabetics 3600 gm. and 51.0 cm. Thus on average infants of diabetics weigh 550 gm. more and are 1.5 cm. longer than are infants of non-diab. Differences of the same magnitude were found in primiparae and in multiparae with and without obesity. The frequency distribution curves for weight and length are nearly normal, but placed at higher levels than are those of non-diab. infants. Diabetics get big and small infants as others, but the whole population is bigger than that of non-diabetics' infants. There is an actual overgrowth. In a personal series from 1946–1953 75 infants of long-term treated (1. t.) were compared to 91 infants of short-term treated (sh. t.) diabetics. The foetal age was 237 days or more, on average 260 days. Average weight and length for 1. t. infants was 3380 gm. and 50.5 cm., for sh. t. 3570 gm. and 51.3 cm. Thus the 1. t. infants on average weighed 190 gm. less and were 0.8 cm. shorter than sh. t. infants. So far these differences are not statistically significant, but an inverse correlation between the length of the last consecutive stay of the mother in Department B and the infants' weight and length could be demon I. Published in extenso in Acta endocrinol. 16, 330, 1954. strated. As the length of stay increases, weight and length decreases. This indicates the differences found to be due to the length of our treatment. As there is a positive correlation between the maternal pregnancy level of blood sugar (foetal glucose supply) during the last 6–7 weeks of pregnancy and the birth weight and length of infants of non-diabetic controls, 1. t. and sh. t. diabetics, the maternal pregnancy level may play a part of its own for the differences found in weight and length of the infants in these 3 groups. The maternal blood sugar level may influence weight and length of the infants directly (foetal glucose consumption) but also indirectly (foetal insulin turn-over rising with a rising supply of glucose), as foetal insulin may act as a growth stimulating factor.


2019 ◽  
Vol 47 (8) ◽  
pp. 894-896
Author(s):  
Viola Leidner ◽  
Filiz Markfeld-Erol ◽  
Matthias Wuttke ◽  
Mirjam Kunze ◽  
Julia Jacobs ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-7
Author(s):  
Jumana Saleh ◽  
Lovina Machado ◽  
Zahra Razvi

Introduction. Increased neonatal birth weight (NBW), often associated with diabetic pregnancies, is a recognized indicator of childhood obesity and future metabolic risk. Predictors of NBW in healthy non-diabetic pregnancies are not yet established. Here, we investigated the association of maternal parameters of healthy non-diabetic mothers with NBW of their “appropriate-for-gestational age” neonates.Methods. The study involved 36 healthy mother/infant pairs. Examined parameters included NBW, maternal age, first and last trimester (BMI), weight gain, fasting serum lipids and glucose, 2-hour postload glucose levels and blood pressure.Results. Postload-glucose levels were significantly higher in mothers of heavier neonates. ANOVA results indicated that 15% increase in postload-glucose levels corresponded to more than 0.5 Kg increase in NBW in the third tertile. NBW correlated positively with postload glucose levels, and negatively with systolic blood pressure. Regression analysis showed that the main predictors of NBW were postload-glucose levels (B=0.455,P=0.003), followed by systolic blood pressure (B=−0.447,P=0.004), together predicting 31.7% NBW variation.Conclusion. This study highlights that increased maternal postload sugar levels and blood pressure, within the normal range, highly predicts NBW of healthy mothers. These findings may provide focus for early dietary intervention measures to avoid future risks to the mother and baby.


PEDIATRICS ◽  
1990 ◽  
Vol 85 (5) ◽  
pp. 834-837
Author(s):  
◽  
Marvin Cornblath ◽  
Robert Schwartz ◽  
Albert Aynsley-Green ◽  
June K. Lloyd

A discussion meeting was held on October 17, 1989, to address the current status of the definition of significant hypoglycemia in infancy, especially in the normal- and low-birth-weight neonate. Robert Schwartz introduced the complexity of the problem by indicating the multiple variables (duration, severity, cerebral blood flow, rates of glucose uptake, availability of alternate substrates, oxygen, etc) in equating a plasma glucose value with neurodevelopmental consequences. Marvin Cornblath reviewed the various definitions of hypoglycemic blood sugar levels reported since 1911 which depend upon the method of blood sugar analysis, clinical recognition and concerns. Severe symptomatic hypoglycemia that persisted or recurred was first reported in neonates in 1937. Lower blood sugar levels, documented since the 1920s in both full-term and premature newborns, had been considered physiologic. The recognition of transient significant hypoglycemia first in symptomatic and then in asymptomatic small-for-gestational-age, neonates required new definitions in the 1960s. These definitions were later modified as changes in treating both the mother in labor and at delivery and the neonate occurred. Intensive care and the survival of very-low-birth-weight newborns have compounded the problem of definition. Currently methods are available to correlate plasma glucose concentrations and glucose metabolism in vivo in the brain with specific neurologic dysfunctions. This should permit a better definition of the continuum of significant hypoglycemia than has been available before. William Hay analyzed studies of the various rapid bedside glucose oxidase stick techniques used to screen for blood glucose concentrations. He concluded that their dependence on the hematocrit, their requirements for precision in performance and timing, great variance (±5 to 15 mg/dL), and lack of reproducibility, especially at blood glucose values less than 50 mg/dL, made their use in the neonate unsatisfactory (whether read by eye or by meter).


1985 ◽  
Vol 54 (02) ◽  
pp. 413-414 ◽  
Author(s):  
Margarethe Geiger ◽  
Bernd R Binder

SummaryWe have demonstrated previously that fibrin enhanced plasmin formation by the vascular plasminogen activator was significantly impaired, when components isolated from the plasma of three uncontrolled diabetic patients (type I) were used to study plasminogen activation in vitro. In the present study it can be demonstrated that functional properties of the vascular plasminogen activators as well as of the plasminogens from the same three diabetic patients are significantly improved after normalization of blood sugar levels and improvement of HbAlc values. Most pronounced the Km of diabetic vascular plasminogen activator in the presence of fibrin returned to normal values, and for diabetic plasminogen the prolonged lag period until maximal plasmin formation occurred was shortened to almost control values. From these data we conclude that the observed abnormalities of in vitro fibrinolysis are not primarily associated with the diabetic disease, but might be secondary to metabolic disorders caused by diabetes.


1972 ◽  
Vol 33 (3) ◽  
pp. 722-733 ◽  
Author(s):  
John W. Dundee ◽  
Martin Isaac ◽  
Elizabeth A. Davis ◽  
Brian Sheridan

Sign in / Sign up

Export Citation Format

Share Document